Blanket Purchase Agreement 36C25626A0017
- Not listed
- Optum Infusion Services 308, LLC, a subsidiary of UnitedHealth Group Incorporated, was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs Veterans Integrated Service Network 16 on October 15, 2025, with a ceiling value of $1.5 million and a performance period extending through September 30, 2030. This contract procures contingency hazardous compounded sterile pharmaceutical products services, specifically the aseptic compounding of chemotherapy agents for...
- The Department of Veterans Affairs, Veterans Integrated Service Network 16 (VISN 16), awarded a single-award Indefinite Delivery Contract valued at $6.75M to Optum Infusion Services 308, LLC, a subsidiary of UnitedHealth Group Incorporated, for pharmacy hazardous compounding services. The contract period extends from October 1, 2024 through September 30, 2029, with no set-aside designation and full and open competition. The scope encompasses the preparation of specialized pharmaceutical...
- This indefinite delivery contract was awarded by the U.S. Department of Veterans Affairs (VA) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated. The $2,012,758.65 single-award contract, which has a period of performance ending on September 30, 2026, is for the provision of compounded chemotherapy and other specialized pharmaceutical services primarily to support the VA's Veterans Health Administration. The contract originated from an unrestricted/full and open...
- Optum Infusion Services 308, LLC, a subsidiary of UnitedHealth Group Incorporated, was awarded a single-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract by the Veterans Integrated Service Network 17 (VISN 17) of the Department of Veterans Affairs on November 1, 2025. The contract, valued at $500,000 ceiling with a guaranteed minimum of $1,000, extends through October 31, 2030, and provides chemotherapy preparation and compounding services for the Amarillo VA Medical Center in...
- The Department of Veterans Affairs Veterans Health Administration (VA-VHA) has awarded an Indefinite Delivery Contract (IDC) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, for the provision of hazardous sterile compounding services. The contract, valued at $2,433,675.00, has a period of performance through October 1, 2024 and was awarded without any set-aside designation, indicating it was a full and open commercial competition. Under this IDC, the VA-VHA has...
- This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 15 to the prime contractor Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated. The contract has a ceiling value of $4,150,000.00 and a performance period through February 28, 2026. The contract aims to procure sterile hazardous drug compounding services, including the preparation of customized chemotherapy agents, hazardous sterile...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 awarded a single award, indefinite delivery contract valued at up to $4,050,000 to Optum Pharmacy 801, Inc., doing business as Avella Specialty Pharmacy, a subsidiary of UnitedHealth Group Incorporated. Two firm fixed price delivery orders have been issued against the contract to date for 503A Pharmaceutical Drug Compounding Services. The first delivery order, issued on August 25, 2023, is...
- This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) and Veterans Health Administration (VHA) to Optum Pharmacy 601, LLC, a subsidiary of UnitedHealth Group Incorporated. The contract has a ceiling value of $416,900.00 and a period of performance through November 19, 2025. Optum Pharmacy 601 is providing chemotherapy compound drug hood services to support veterans' healthcare programs, particularly through the VA's Veterans Integrated Service Networks...
- Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, was awarded a single-award Indefinite Delivery Contract valued at $20,000 by the Department of Veterans Affairs' Veterans Integrated Service Network 20 (VISN 20) for pharmacy hazardous compounding services. The contract runs from October 1, 2025, through September 30, 2030, with performance conducted at the contractor's facility in Phoenix, Arizona. This IDC serves as a contingency framework for sterile intravenous...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded an Indefinite Delivery Contract (IDC) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, to provide nationwide pharmacy compounding services. The contract has a ceiling value of $10,000,000 and a period of performance through October 31, 2025. Under this IDC, Optum Pharmacy 801, Inc. (doing business as Avella Specialty Pharmacy) will provide highly specialized pharmaceutical...
The Department of Veterans Affairs Veterans Health Administration awarded a single-award Blanket Purchase Agreement valued at $750,000.00 to Optum Infusion Services 308, LLC (a subsidiary of UnitedHealth Group Incorporated) on December 25, 2025, for the provision of contingency pharmacy compounding products and services. The contract, which runs through December 25, 2030, establishes an indefinite delivery vehicle for aseptically compounded hazardous chemotherapy agents and related pharmaceutical supplies supporting the Central Arkansas Veterans Healthcare System. The scope encompasses patient-specific chemotherapy preparations, intravenous tubing, and closed-system drug transfer devices, with delivery requirements mandating next-day availability by 9:00 AM to the inpatient pharmacy located at 4300 West 7th Street, Building 7D-136, in Little Rock, Arkansas. The procurement was conducted as an unrestricted acquisition under simplified acquisition procedures with no set-aside designation, utilizing NAICS code 325412 (Pharmaceutical Preparation Manufacturing). The awarded contractor must maintain current pharmacy licensure and demonstrate full compliance with United States Pharmacopeia standards 797, 795, and 800, along with Food and Drug Administration 503A compliance for hazardous compounding operations. The solicitation required vendors to submit comprehensive price schedules covering an extensive range of chemotherapy agents and pharmaceutical supplies across multiple pricing tiers for the base year and four option years, with invoicing limited to contract line items actually utilized. Critical contractor qualifications included absence of pending FDA consent decrees, demonstrated capability in hazardous chemotherapy compounding, and appropriate courier training for the transport of controlled pharmaceutical products. The contract structure establishes a Not-to-Exceed annual amount with actual payments contingent upon task orders or purchase requests issued by the Veterans Health Administration.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 11/17/25 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6505--Contingency Pharmacy Compounding Products-Services 36C25626Q0026 | 36C25626Q0026 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 | Solicitation 1/2 | 10/21/25, 3:37 PM | |
6505--Contingency Pharmacy Compounding Products-Services 36C25626Q0026 | 36C25626Q0026 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 | Award Notice 2/2 | 11/18/25, 8:01 AM |